Research Article
Hemangiopericytoma: Incidence, Treatment, and Prognosis Analysis Based on SEER Database
Table 2
TNM and SEER stages in the hemangiopericytoma patient cohort.
| Hemangiopericytoma (AJCC stage 7th edition) | | Number | Percent (%) | | Number | Percent (%) |
| T stage | | | SEER stage | | | T1 | 35 | 20.6 | Localized | 442 | 37.8 | T2 | 120 | 70.6 | Regional | 197 | 16.9 | Unknown | 15 | 8.8 | Distant | 115 | 9.8 | N stage | | | Unstaged | 415 | 34.7 | N0 | 165 | 90.2 | Grade | | | N1 | 2 | 1.1 | I | 142 | 14.9 | Unknown | 16 | 8.7 | II | 37 | 3.9 | M stage | | | III | 86 | 9.0 | M0 | 164 | 89.6 | IV | 136 | 14.3 | M1 | 19 | 10.4 | Unknown | 552 | 57.9 | AJCC stage | | | | | | I | 95 | 55.2 | | | | II | 17 | 9.9 | | | | III | 34 | 19.8 | | | | IV | 19 | 11.0 | | | | Unknown | 7 | 4.1 | | | |
|
|
TNM: tumor-node-metastasis; SEER: Surveillance, Epidemiology, and End Results; AJCC: American Joint Committee on Cancer.
|